Hypertension due to blockade of adenosine receptors

Pharmacology and Toxicology

Volumn 92, Issue 4, 2003, Pages 160-162

  Guimarães, Serafim ^a,b   Morato, Manuela ^a   Sousa, Teresa ^a   Albino Teixeira, António ^a  

^a University of Porto   (Portugal)

^b Inst of Pharmacol and Therapeutics   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 DIPROPYL 8 (4 SULFOPHENYL)XANTHINE; ADENOSINE RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BRIMONIDINE; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ISOPRENALINE; LOSARTAN; N(G) NITROARGININE METHYL ESTER; NORADRENALIN;

ADRENERGIC TRANSMISSION; BLOOD VESSEL DIAMETER; BLOOD VESSEL FUNCTION; BLOOD VESSEL WALL; CONCENTRATION RESPONSE; CONFERENCE PAPER; DISEASE COURSE; DRUG EFFECT; ELECTROSTIMULATION; HEART FUNCTION; HYPERTENSION; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE; TUNICA MEDIA;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HEART; HYPERTENSION; NOREPINEPHRINE; RATS; RATS, WISTAR; RECEPTORS, PURINERGIC P1; XANTHINES;

EID: 0037392393     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2003.920404.x     Document Type: Conference Paper

References (12)

1. Albino-Teixeira, A., I. Azevedo, D. Branco & W. Osswald: Purine agonists prevent trophic changes caused by sympathetic denervation. Eur. J. Pharmacol. 1990, 179, 141-149.
2. Albino-Teixeira, A., A. Matias, J. Polónia & I. Azevedo: Blockade of adenosine receptors causes hypertension and cardiovascular structural changes in the rat. J. Hypertens. 1991, 191(Suppl 6), S196-S197.
3. Albino-Teixeira, A.: The prolonged infusion of 1,3-dipropyl-8-sulfophenylxanthine exarcebates renal hypertension in the rat. J. Auton. Pharmacol. 1996, 17, 225P.
4. 1-purinoceptors. J. Auton. Pharmacol. 1996, 16, 367-370.
5. Guimarães, S., F. Brandão & M.Q. Paiva: A study of the adrenoceptor-mediated feedback mechanism by using adrenaline as a false transmitter. Naunyn-Schmiedeberg's Arch. Pharmacol. 1978, 305, 185-188.
6. 2-adrenoceptor-mediated effects at pre- but not at postjunctional level. Naunyn-Schmiedeberg's Arch Pharmacol. 1994, 350, 692-695.
7. Guimarães, S., A. Albino-Teixeira & M.Q. Paiva: Hypertension and enhanced β-adrenoceptor-mediated facilitation of noradrenaline release produced by chronic blockade of adenosine receptors. Brit. J. Pharmacol. 1995, 114, 1595-1598.
8. Karoon, P., A. Rubino & G. Burnstock: Hypertension induced by 1,3-dipropyl-8-sulfo-phenylxanthine (DPSPX): Effects on sympathetic neurotransmission in the rat tail artery. Brit. J. Pharmacol. 1995, 114 (Suppl) 399P.
9. Kuan, C. J., J. N. Wells & E. K. Jackson: Endogenous adenosine restrains renin release in conscious rats. Circ. Res. 1990, 66, 637-646.
10. 1-purinoceptors with 1,3-dipropyl-8-sulphophenylxanthine (DPSPX). Br. J. Pharmacol. 1995, 114 (Suppl), 105P.
11. Rubino, A. & G. Burnstock: Changes in sympathetic neurotransmission and adrenergic control of cardiac contractility during 1,3-dipropyl-8-sulphophenylxanthine-induced hypertension. J. Pharmacol. Exp. Ther. 1995, 275, 422-428.
12. Sousa, T., M. Morato, S. Guimarães, D. Moura, & A. Albino-Teixeira: Vascular and myocardial effects of losartan and atenolol in 1,3-dipropyl-8-sulfophenylxanthine-hypertension. Fund. Clin. Pharmacol. 2001, 15 (Suppl 1) 90.